Brief: Dermapharm Holding Confirms Full-Year Guidance

Dermapharm Holding SE

15/05/2025 06:36

May 15 (Reuters) - Dermapharm Holding SE DMPG.DE:

DERMAPHARM Q1 ADJUSTED EBITDA MARGIN 26.9%

DERMAPHARM Q1 REVENUE EUR 302.4 MILLION

DERMAPHARM Q1 ADJUSTED EBITDA EUR 81.3 MILLION

DERMAPHARM Q1 EBITDA EUR 80.1 MILLION

DERMAPHARM Q1 EBITDA MARGIN 26.5%

CONFIRMS FULL-YEAR GUIDANCE

Source text: ID:nEQ471t3ka

Further company coverage: DMPG.DE

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))